Rev. Saúde Pública 2003;28(2):116-120


Capture erytroimmunoadsorption test for neurocysticercosis immunodiagnosis

Carmen Silvia de M. , Sandra Maria Ottati de Oliveira

DOI: 10.1590/S0034-89101994000200004

The capture erytroimmunoadsorption (C-EIA) test was standardized for detection of Taenia solium cysticercus-IgG specific antibodies in cerebrospinal fluid (CSF) from patients with ncurocysticercosis. For the C-EIA test performance a reagent for specific antibody detection was prepared using sheep’s red blood cells (SRBC) in a concentration of 0.25% sensitized with crude saline extract antigen (SEA) obtained from Cysticercus cellulosae. The optimum concentration of SEA for SRBC sensitization was 40ug/ml. The yield of SEA was 0.lug protein/cavity. When 58 CSF samples from patients with neurocysticercosis were analysed the sensitivity of the test was found to be 84.5% and the confidence limit of 95% probability (CL 95%) ranged from 75% to 94%. The specificity was 95.3% (CL 95% from 90.7% to 99.9%) when CSF samples from the control group were analysed. The C-EIA test was shown to be efficient for neurocysticercosis diagnosis and important for public health laboratories, because of its low cost, high reagent yield and ease of use.

Capture erytroimmunoadsorption test for neurocysticercosis immunodiagnosis

Comments

Skip to content